Navigation Links
Cephalon's 2007 Results Exceed Full Year Sales and Earnings Guidance
Date:2/12/2008

ling, general and administrative expenses and $11.7 million in

Income tax expense related to SFAS 123(R).

CEPHALON, INC. AND SUBSIDIARIES

"ADJUSTED" CONSOLIDATED SALES DETAIL *

(In thousands)

(Unaudited)

Three Months Ended

December 31,

2007

United

States Europe Total

Sales:

PROVIGIL $208,245 $11,237 $219,482

GABITRIL 10,828 400 11,228

CNS 219,073 11,637 230,710

ACTIQ 42,310 12,027 54,337

Generic OTFC 31,471 - 31,471

FENTORA 33,912 - 33,912

AMRIX 8,401 - 8,401

Pain 116,094 12,027 128,121

Other 15,396 65,270 80,666

$350,563 $88,934 $439,497

Three Months Ended

December 31,

2006

United

States Europe Total

Sales:

PROVIGIL $190,838 $13,833 $204,671

GABITRIL 12,805 806 13,611

CNS 203,643 14,639 218,282

ACTIQ 100,882 8,039 108,921

Generic OTFC
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
4. CNS Response Announces Fiscal Third Quarter 2007 Results
5. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
6. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
7. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
8. Carrington Reports Second Quarter 2007 Results
9. Avitar Reports Third Quarter Financial Results for Fiscal 2007
10. Response Genetics Reports Second Quarter 2007 Financial Results
11. Martek to Announce Third Quarter 2007 Results on September 5, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):ISWA calls attention to important contribution of waste sector to reduce substantial CO2 emissions 2Self-destructing bacteria improve renewable biofuel production 2Self-destructing bacteria improve renewable biofuel production 3Researchers demonstrate nanoscale X-ray imaging of bacterial cells 2NBTY to Webcast Presentation at Oppenheimer 9th Annual Consumer Gaming Lodging 26 Leisure Conference 3B Announces Fiscal Third Quarter Preliminary 51303 1NBTY to Webcast Presentation at Oppenheimer 9th Annual Consumer Gaming Lodging 26 Leisure Conference 3B Announces Fiscal Third Quarter Preliminary 51303 2NBTY to Webcast Presentation at Oppenheimer 9th Annual Consumer Gaming Lodging 26 Leisure Conference 3B Announces Fiscal Third Quarter Preliminary 51303 3NBTY to Webcast Presentation at Oppenheimer 9th Annual Consumer Gaming Lodging 26 Leisure Conference 3B Announces Fiscal Third Quarter Preliminary 51303 4Poll of Business Executives Shows Most Companies Not Aware of True Costs of Healthcare 51301 1Poll of Business Executives Shows Most Companies Not Aware of True Costs of Healthcare 51301 2Poll of Business Executives Shows Most Companies Not Aware of True Costs of Healthcare 51301 3Poll of Business Executives Shows Most Companies Not Aware of True Costs of Healthcare 51301 4Cord Blood America Hires Management Team for Its New Stem Cell Laboratory 51299 1Cord Blood America Hires Management Team for Its New Stem Cell Laboratory 51299 2Cord Blood America Hires Management Team for Its New Stem Cell Laboratory 51299 3